NLRP7 Enhances Choriocarcinoma Cell Survival and Camouflage in an Inflammasome Independent Pathway

Background: Gestational choriocarcinoma (GC) is a highly malignant trophoblastic tumor that often develops from a complete hydatidiform mole (HM). <i>NLRP7</i> is the major gene responsible for recurrent HM and is involved in the innate immune response, inflammation and apoptosis. NLRP7...

Full description

Bibliographic Details
Main Authors: Déborah Reynaud, Nadia Alfaidy, Constance Collet, Nicolas Lemaitre, Frederic Sergent, Céline Miege, Emmanuelle Soleilhac, Alaa Al Assi, Padma Murthi, Gilles Courtois, Marie-Odile Fauvarque, Rima Slim, Mohamed Benharouga, Roland Abi Nahed
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/12/6/857
_version_ 1797612886452862976
author Déborah Reynaud
Nadia Alfaidy
Constance Collet
Nicolas Lemaitre
Frederic Sergent
Céline Miege
Emmanuelle Soleilhac
Alaa Al Assi
Padma Murthi
Gilles Courtois
Marie-Odile Fauvarque
Rima Slim
Mohamed Benharouga
Roland Abi Nahed
author_facet Déborah Reynaud
Nadia Alfaidy
Constance Collet
Nicolas Lemaitre
Frederic Sergent
Céline Miege
Emmanuelle Soleilhac
Alaa Al Assi
Padma Murthi
Gilles Courtois
Marie-Odile Fauvarque
Rima Slim
Mohamed Benharouga
Roland Abi Nahed
author_sort Déborah Reynaud
collection DOAJ
description Background: Gestational choriocarcinoma (GC) is a highly malignant trophoblastic tumor that often develops from a complete hydatidiform mole (HM). <i>NLRP7</i> is the major gene responsible for recurrent HM and is involved in the innate immune response, inflammation and apoptosis. NLRP7 can function in an inflammasome-dependent or -independent pathway. Recently, we have demonstrated that <i>NLRP7</i> is highly expressed in GC tumor cells and contributes to their tumorigenesis. However, the underlying mechanisms are still unknown. Here, we investigated the mechanism by which NLRP7 controls these processes in malignant (JEG-3) and non-tumor (HTR8/SVneo) trophoblastic cells. Cell survival, dedifferentiation, camouflage, and aggressiveness were compared between normal JEG-3 cells or knockdown for <i>NLRP7,</i> JEG-3 Sh <i>NLRP7</i>. In addition, HTR8/SVneo cells overexpressing <i>NLRP7</i> were used to determine the impact of <i>NLRP7</i> overexpression on non-tumor cells. NLRP7 involvement in tumor cell growth and tolerance was further characterized in vivo using the metastatic mouse model of GC. Results: We demonstrate that NLRP7 (i) functions in an inflammasome-dependent and -independent manners in HTR8/SVneo and JEG-3 cells, respectively; (ii) differentially regulates the activity of NF-κB in tumor and non-tumor cells; (iii) increases malignant cell survival, dedifferentiation, and camouflage; and (iv) facilitates tumor cells colonization of the lungs in the preclinical model of GC. Conclusions: This study demonstrates for the first time the mechanism by which NLRP7, independently of its inflammasome machinery, contributes to GC growth and tumorigenesis. The clinical relevance of NLRP7 in this rare cancer highlights its potential therapeutic promise as a molecular target to treat resistant GC patients.
first_indexed 2024-03-11T06:48:10Z
format Article
id doaj.art-f4b51aa30b714a239a34a543de1d478d
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-11T06:48:10Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-f4b51aa30b714a239a34a543de1d478d2023-11-17T10:12:51ZengMDPI AGCells2073-44092023-03-0112685710.3390/cells12060857NLRP7 Enhances Choriocarcinoma Cell Survival and Camouflage in an Inflammasome Independent PathwayDéborah Reynaud0Nadia Alfaidy1Constance Collet2Nicolas Lemaitre3Frederic Sergent4Céline Miege5Emmanuelle Soleilhac6Alaa Al Assi7Padma Murthi8Gilles Courtois9Marie-Odile Fauvarque10Rima Slim11Mohamed Benharouga12Roland Abi Nahed13Institut National de la Santé et de la Recherche Médicale U1292, Biologie et Biotechnologie pour la Santé, 38043 Grenoble, FranceInstitut National de la Santé et de la Recherche Médicale U1292, Biologie et Biotechnologie pour la Santé, 38043 Grenoble, FranceInstitut National de la Santé et de la Recherche Médicale U1292, Biologie et Biotechnologie pour la Santé, 38043 Grenoble, FranceInstitut National de la Santé et de la Recherche Médicale U1292, Biologie et Biotechnologie pour la Santé, 38043 Grenoble, FranceInstitut National de la Santé et de la Recherche Médicale U1292, Biologie et Biotechnologie pour la Santé, 38043 Grenoble, FranceInstitut National de la Santé et de la Recherche Médicale U1292, Biologie et Biotechnologie pour la Santé, 38043 Grenoble, FranceUniversity Grenoble Alpes, Inserm, CEA, UA13 BGE, 38000 Grenoble, FranceLaboratory of Fundamental and Applied Bioenergetics (LBFA), Univeristy Grenoble Alpes, Inserm, 38000 Grenoble, FranceDepartment of Pharmacology, Monash Biomedicine Discovery Institute, Monash University, Melbourne VIC 3800, AustraliaUniversity Grenoble Alpes, Inserm, CEA, UA13 BGE, 38000 Grenoble, FranceUniversity Grenoble Alpes, Inserm, CEA, UA13 BGE, 38000 Grenoble, FranceDepartments of Human Genetics and Obstetrics and Gynecology, McGill University Health Centre Research Institute, Montréal, QC H4A 3J1, CanadaInstitut National de la Santé et de la Recherche Médicale U1292, Biologie et Biotechnologie pour la Santé, 38043 Grenoble, FranceInstitut National de la Santé et de la Recherche Médicale U1292, Biologie et Biotechnologie pour la Santé, 38043 Grenoble, FranceBackground: Gestational choriocarcinoma (GC) is a highly malignant trophoblastic tumor that often develops from a complete hydatidiform mole (HM). <i>NLRP7</i> is the major gene responsible for recurrent HM and is involved in the innate immune response, inflammation and apoptosis. NLRP7 can function in an inflammasome-dependent or -independent pathway. Recently, we have demonstrated that <i>NLRP7</i> is highly expressed in GC tumor cells and contributes to their tumorigenesis. However, the underlying mechanisms are still unknown. Here, we investigated the mechanism by which NLRP7 controls these processes in malignant (JEG-3) and non-tumor (HTR8/SVneo) trophoblastic cells. Cell survival, dedifferentiation, camouflage, and aggressiveness were compared between normal JEG-3 cells or knockdown for <i>NLRP7,</i> JEG-3 Sh <i>NLRP7</i>. In addition, HTR8/SVneo cells overexpressing <i>NLRP7</i> were used to determine the impact of <i>NLRP7</i> overexpression on non-tumor cells. NLRP7 involvement in tumor cell growth and tolerance was further characterized in vivo using the metastatic mouse model of GC. Results: We demonstrate that NLRP7 (i) functions in an inflammasome-dependent and -independent manners in HTR8/SVneo and JEG-3 cells, respectively; (ii) differentially regulates the activity of NF-κB in tumor and non-tumor cells; (iii) increases malignant cell survival, dedifferentiation, and camouflage; and (iv) facilitates tumor cells colonization of the lungs in the preclinical model of GC. Conclusions: This study demonstrates for the first time the mechanism by which NLRP7, independently of its inflammasome machinery, contributes to GC growth and tumorigenesis. The clinical relevance of NLRP7 in this rare cancer highlights its potential therapeutic promise as a molecular target to treat resistant GC patients.https://www.mdpi.com/2073-4409/12/6/857NLRP7inflammasomegestational choriocarcinomacamouflageNF-κBcancer
spellingShingle Déborah Reynaud
Nadia Alfaidy
Constance Collet
Nicolas Lemaitre
Frederic Sergent
Céline Miege
Emmanuelle Soleilhac
Alaa Al Assi
Padma Murthi
Gilles Courtois
Marie-Odile Fauvarque
Rima Slim
Mohamed Benharouga
Roland Abi Nahed
NLRP7 Enhances Choriocarcinoma Cell Survival and Camouflage in an Inflammasome Independent Pathway
Cells
NLRP7
inflammasome
gestational choriocarcinoma
camouflage
NF-κB
cancer
title NLRP7 Enhances Choriocarcinoma Cell Survival and Camouflage in an Inflammasome Independent Pathway
title_full NLRP7 Enhances Choriocarcinoma Cell Survival and Camouflage in an Inflammasome Independent Pathway
title_fullStr NLRP7 Enhances Choriocarcinoma Cell Survival and Camouflage in an Inflammasome Independent Pathway
title_full_unstemmed NLRP7 Enhances Choriocarcinoma Cell Survival and Camouflage in an Inflammasome Independent Pathway
title_short NLRP7 Enhances Choriocarcinoma Cell Survival and Camouflage in an Inflammasome Independent Pathway
title_sort nlrp7 enhances choriocarcinoma cell survival and camouflage in an inflammasome independent pathway
topic NLRP7
inflammasome
gestational choriocarcinoma
camouflage
NF-κB
cancer
url https://www.mdpi.com/2073-4409/12/6/857
work_keys_str_mv AT deborahreynaud nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT nadiaalfaidy nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT constancecollet nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT nicolaslemaitre nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT fredericsergent nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT celinemiege nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT emmanuellesoleilhac nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT alaaalassi nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT padmamurthi nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT gillescourtois nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT marieodilefauvarque nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT rimaslim nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT mohamedbenharouga nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway
AT rolandabinahed nlrp7enhanceschoriocarcinomacellsurvivalandcamouflageinaninflammasomeindependentpathway